DraftKings Inc. Cl A Stock Climbs 4.4%, Outperforms Market
Dow Jones2026/08/11 20:34This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of DraftKings Inc. Cl A advanced 4.4% to $25.34 on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.6% to 26,445.45 and Dow Jones Industrial Average falling 0.3% to 53,791.85.
This was the stock's fourth consecutive day of gains.
DraftKings Inc. Cl A closed 48.1% short of its 52-week high of $48.78, which the company reached on September 5th.
Trading volume totaled 11.3 million, compared to the 50-day average of 13.6 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
August 11, 2026 16:34 ET (20:34 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
Crypto prices
More
